Mark von Zastrow where she identified novel core cellular machinery critical for G protein-coupled receptor cell biological mechanisms regulating GPCR activity, including spatial control of GPCR signaling and receptor

obtained his Ph.D. from the University of Manitoba – Canada, where he was introduced to G protein-coupled receptors His doctoral research focused on the structural and functional characterization of bitter taste receptors

Since 2013, he has been elected Chair of the subcommittee for the Dopamine receptors of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification

within the research group and used this platform to develop nanobodies targeting viral G protein-coupled receptors with a special focus on the human cytomegalovirus-encoded chemokine receptor US28.

With a special emphasis on G protein coupled receptors and receptor activity modifying proteins in vascular

developing a powerful new computational tool for identifying ‘surrogate’ ligands (borrowed from other receptors this expertise to establish a research program that takes orphan GPCRs from ‘locked’, inaccessible receptors

and received my Ph.D. in Molecular Medicine in 2010 after studying the orphan atypical cannabinoid receptor I studied the function of RGS5, calcium-sensing receptor, and an orphan adhesion GPCR, GPR64/ADGRG2 in

discover and develop highly effective cancer therapeutics by targeting heteromers of G protein-coupled receptors At Medarex, she initiated and identified the lead mAb for the type I interferon-alpha receptor project

thorough and mechanistic understanding of processes that control cell signaling by protease-activated receptors Her laboratory is the recognized expert on protease-activated receptors, particularly PAR1, and over

backgrounds, and career paths, with a focus on their experiences in the field of GPCR (G protein-coupled receptor Scientists Demet and Yamina discussed the progress of their research in the GPCR (G protein-coupled receptor They also discussed the importance of the extracellular region of these receptors and its potential as

What learning from “failed” screens can reveal about receptor pharmacology and species selectivity. The moment when bias agonism and receptor trafficking concepts shifted industry standards for functional

Davide Calebiro | University of Birmingham The spatiotemporal organization of GPCR signalling Receptor The GPCR Masterclass is a live scientific discussion with a leading expert in GPCR pharmacology, receptor

Matters Computational models are moving beyond interpretation into real-world prediction of ligand-receptor His team focuses on understanding how ligands modulate receptor function and how those insights can drive

Yet much remains to be learned about how these 800-plus receptors are expressed and how they function Identifying an immunoreactive antigen sequence that is specific for a single receptor and detectable

GPCR Biology <p class="font_8">Watch Now</p> Bryan Roth GPCR Molecular Glues: Biased Modulation at the Receptor–Transducer The GPCR Masterclass is a live scientific discussion with a leading expert in GPCR pharmacology, receptor

are pleased to welcome you at Le Château Montebello, the 22nd Annual Great Lakes G Protein-Coupled Receptor University of North Carolina at Chapel Hill, unquestionably one of the pioneers involved in deciphering how receptor

GPCR webinars are live online scientific sessions focused on G protein-coupled receptor (GPCR) biology

years of experience in GPCR, primarily focused on drug discovery and developing new tools to study this receptor

Pharmacology of Sherbrooke and is an emerging leader in the structural biology of G Protein-Coupled Receptors

The focus of his research is the molecular pharmacology of cannabinoids and cannabinoid receptors.

Saraf " My research focuses on evaluating and targeting serotonin 1A receptors for therapeutic outcomes

innovating technologies to solve broad questions in pharmacology, with a specific focus on G-protein coupled receptor

Julia studies the mechanisms of 'biased signaling' at GPCRs, with a specific focus on the chemokine receptor

His interests are in receptor pharmacology, allosteric protein function, and drug discovery. Dr.

The majority of my research is concentrated on rhodopsin family with a few works on metabotropic receptor

designed to assess the kinetics of unlabelled compounds (and chemical fragments) and the use of purified receptor

constrained molecular dynamics simulation methods with emphasis on application to G-protein coupled receptors

is currently focused on understanding the signal transduction pathways activated by beta-adrenergic receptors

adapts interdisciplinary approaches (synthesis, modeling, pharmacology) to study G protein-coupled receptors

His main research group centers on the function, structure, and regulation of G protein-coupled receptors